Literature DB >> 20418781

Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations.

Peter T Nelson1, Walter A Kukull, Matthew P Frosch.   

Abstract

The brains of many cognitively impaired patients fall into neuropathologic diagnostic categories that cannot be defined explicitly by guidelines of the National Institute on Aging and Reagan Institute. Here, 2 specific case categories are considered: i) "tangle-intensive" patients with the highest density of neurofibrillary tangles (as graded by the Braak staging system) but only moderate density of neuritic amyloid plaques (as graded by the Consortium to Establish a Registry for Alzheimer's Disease); and ii) "plaque-intensive" patients with intermediate severity neurofibrillary tangles and high density of neuritic amyloid plaques. To understand these technically unclassifiable cases better, we analyzed 1,677 cases with antemortem diagnoses of dementia from the National Alzheimer's Coordinating Center Registry; this registry includes both clinical and pathologic data from the National Institute on Aging-funded Alzheimer Disease Center. To evaluate the diagnostic tendencies of Alzheimer Disease Center neuropathologists, we assessed how the plaque-intensive and tangle-intensive cases were diagnosed. Tangle-intensive cases were more likely to be designated "high likelihood" that the dementia was due to Alzheimer disease, whereas plaque-intensive cases were typically designated as "intermediate likelihood." Only the Braak Stage VI tangle-intensive cases had lower final Mini-Mental State Examination scores than the plaque-intensive cases (p < 0.02). We conclude that more explicit diagnostic categories and a better understanding of the pathology in earlier phases of the disease may be helpful for guiding neuropathologists in the diagnosis of Alzheimer disease.

Entities:  

Mesh:

Year:  2010        PMID: 20418781      PMCID: PMC2892786          DOI: 10.1097/NEN.0b013e3181d8db07

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  21 in total

1.  The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.

Authors:  Duane L Beekly; Erin M Ramos; Gerald van Belle; Woodrow Deitrich; Amber D Clark; Mary E Jacka; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

Review 2.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

Review 3.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

4.  The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary.

Authors:  S S Mirra
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

5.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.

Authors:  P V Arriagada; J H Growdon; E T Hedley-Whyte; B T Hyman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

6.  Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria.

Authors:  G Halliday; T Ng; M Rodriguez; A Harding; P Blumbergs; W Evans; V Fabian; J Fryer; M Gonzales; C Harper; R Kalnins; C L Masters; C McLean; D G Milder; R Pamphlett; G Scott; A Tannenberg; J Kril
Journal:  Acta Neuropathol       Date:  2002-03-22       Impact factor: 17.088

7.  Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.

Authors:  Z Nagy; M M Esiri; K A Jobst; J H Morris; E M King; B McDonald; S Litchfield; A Smith; L Barnetson; A D Smith
Journal:  Dementia       Date:  1995 Jan-Feb

8.  The importance of neuritic plaques and tangles to the development and evolution of AD.

Authors:  P Tiraboschi; L A Hansen; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

9.  Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.

Authors:  M Ingelsson; H Fukumoto; K L Newell; J H Growdon; E T Hedley-Whyte; M P Frosch; M S Albert; B T Hyman; M C Irizarry
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

Review 10.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

View more
  22 in total

1.  Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: a combined neuropathology and high-resolution ex vivo MRI analysis.

Authors:  Jean C Augustinack; Kristen E Huber; Gheorghe M Postelnicu; Sita Kakunoori; Ruopeng Wang; André J W van der Kouwe; Lawrence L Wald; Thor D Stein; Matthew P Frosch; Bruce Fischl
Journal:  Acta Neuropathol       Date:  2011-12-13       Impact factor: 17.088

2.  Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.

Authors:  Karen S SantaCruz; Joshua A Sonnen; Maryam Kherad Pezhouh; Mark F Desrosiers; Peter T Nelson; Suzanne L Tyas
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

3.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

4.  Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Authors:  Thomas G Beach; Sarah E Monsell; Leslie E Phillips; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

5.  Biomarkers in Alzheimer's disease drug development.

Authors:  Kaj Blennow
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

Review 6.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

7.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

8.  The temporospatial evolution of neuritic plaque-related and independent tauopathies: implications for dementia staging.

Authors:  Donald R Royall; Raymond F Palmer
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.

Authors:  Ann Hake; Paula T Trzepacz; Shufang Wang; Peng Yu; Michael Case; Helen Hochstetler; Michael M Witte; Elisabeth K Degenhardt; Robert A Dean
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

10.  Applicability of digital analysis and imaging technology in neuropathology assessment.

Authors:  William D Dunn; Marla Gearing; Yuna Park; Lifan Zhang; John Hanfelt; Jonathan D Glass; David A Gutman
Journal:  Neuropathology       Date:  2015-11-18       Impact factor: 1.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.